EUA
COVID-19 RT-PCR Peptide Nucleic Acid (PNA) kit
FDA Emergency Use Authorization · BioTNS Co. Ltd. · May 28, 2021
Key facts
| Product | COVID-19 RT-PCR Peptide Nucleic Acid (PNA) kit |
|---|---|
| Company | BioTNS Co. Ltd. |
| Product type | RT-PCR, Multiple Targets |
| Date | May 28, 2021 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: